<main class="publication" lang="en" role="main">
      
<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Decision
  </span>

  
  <h1 class="gem-c-title__text govuk-heading-l">
    Regulatory approval of Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
  </h1>
</div>
  </div>
  

  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">Information for healthcare professionals and the public about Vaxzevria (previously COVID-19 Vaccine AstraZeneca).</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata" data-module="gem-toggle">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a href="/government/organisations/medicines-and-healthcare-products-regulatory-agency" class="govuk-link">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">30 December 2020</dd>
      <dt class="gem-c-metadata__term">Last updated</dt>
      <dd class="gem-c-metadata__definition">
        21 October 2021
          â€” <a href="#history" class="gem-c-metadata__definition-link govuk-!-display-none-print" data-track-category="content-history" data-track-label="history" data-track-action="see-all-updates-link-clicked">
            See all updates
          </a>
      </dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>





<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="responsive-bottom-margin">
      


      <div class="responsive-bottom-margin">
          <section>
    <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Documents</h2>


      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
        <section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" tabindex="-1" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174">Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1026597/uk-clean-spc-covid-19-vaccine-astrazeneca-reg174__1_.pdf"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1026597/thumbnail_uk-clean-spc-covid-19-vaccine-astrazeneca-reg174__1_.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1026597/uk-clean-spc-covid-19-vaccine-astrazeneca-reg174__1_.pdf">Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">167KB</span>, <span class="page-length" lang="en">13 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-uk-recipients-on-covid-19-vaccine-astrazeneca" class="thumbnail"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-uk-recipients-on-covid-19-vaccine-astrazeneca">Information for UK recipients on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1025949/uk-annotated-pl-covid-19-vaccine-astrazeneca-reg174.pdf" tabindex="-1" class="thumbnail"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1025949/thumbnail_uk-annotated-pl-covid-19-vaccine-astrazeneca-reg174.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1025949/uk-annotated-pl-covid-19-vaccine-astrazeneca-reg174.pdf">Information for UK recipients on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">154KB</span>, <span class="page-length" lang="en">7 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca" tabindex="-1"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca">Conditions of Authorisation for COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016207/AZ_Conditions__-_9SEPT21.pdf" class="thumbnail" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016207/thumbnail_AZ_Conditions__-_9SEPT21.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016207/AZ_Conditions__-_9SEPT21.pdf">Conditions of Authorisation for COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">267KB</span>, <span class="page-length" lang="en">11 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca">Summary of Product Characteristics for Vaxzevria </a></h3>
    <p class="metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027444/gb-spc-covid-19-vaccine-astrazeneca-gbs-2-clean_21Oct.pdf" class="thumbnail" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027444/thumbnail_gb-spc-covid-19-vaccine-astrazeneca-gbs-2-clean_21Oct.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027444/gb-spc-covid-19-vaccine-astrazeneca-gbs-2-clean_21Oct.pdf">Summary of Product Characteristics for Vaxzevria</a></h3>
    <p class="metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">210KB</span>, <span lang="en" class="page-length">11 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/patient-information-leaflet-for-covid-19-vaccine-astrazeneca" class="thumbnail" tabindex="-1"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/patient-information-leaflet-for-covid-19-vaccine-astrazeneca">Patient Information Leaflet for Vaxzevria </a></h3>
    <p class="metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027441/gb-pl-covid-19-vaccine-astrazeneca-gbs-2-clean_21Oct.pdf" tabindex="-1" class="thumbnail"><img src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027441/thumbnail_gb-pl-covid-19-vaccine-astrazeneca-gbs-2-clean_21Oct.pdf.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027441/gb-pl-covid-19-vaccine-astrazeneca-gbs-2-clean_21Oct.pdf">Patient Information Leaflet for Vaxzevria </a></h3>
    <p class="metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">140KB</span>, <span class="page-length" lang="en">7 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca--2" tabindex="-1" class="thumbnail"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca--2">Conditions of Authorisation for Vaxzevria</a></h3>
    <p class="metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" tabindex="-1" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1006741/COVID-19_Vaccine_AstraZeneca_CMA_obligations_final_28_7_21.pdf"><img src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1006741/thumbnail_COVID-19_Vaccine_AstraZeneca_CMA_obligations_final_28_7_21.pdf.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-5801380-accessibility-help" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1006741/COVID-19_Vaccine_AstraZeneca_CMA_obligations_final_28_7_21.pdf">Conditions of Authorisation for Vaxzevria</a></h3>
    <p class="metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">51.2KB</span>, <span lang="en" class="page-length">2 pages</span>
    </p>


      <div data-module="toggle" class="accessibility-warning">
        <p>This file may not be suitable for users of assistive technology.</p>
        <details data-module="govuk-details gem-details" class="gem-c-details govuk-details govuk-!-margin-bottom-3">
  <summary data-track-category="Accessible Format Request" data-track-action="FormatRequestClicked" data-track-label="Conditions of Authorisation for Vaxzevria" data-module="govuk-details" class="govuk-details__summary" data-details-track-click="">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Conditions%20of%20Authorisation%20for%20Vaxzevria%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Conditions%20of%20Authorisation%20for%20Vaxzevria%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/summary-of-the-public-assessment-report-par-for-vaxzevria" tabindex="-1"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/summary-of-the-public-assessment-report-par-for-vaxzevria">Summary of the Public Assessment Report (PAR) for Vaxzevria</a></h3>
    <p class="metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1003840/CMA_UKPAR_COVID_19_Vaccine_AstraZeneca_PAR_16.07.2021.pdf" tabindex="-1" class="thumbnail"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1003840/thumbnail_CMA_UKPAR_COVID_19_Vaccine_AstraZeneca_PAR_16.07.2021.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1003840/CMA_UKPAR_COVID_19_Vaccine_AstraZeneca_PAR_16.07.2021.pdf" aria-describedby="attachment-5801382-accessibility-help">Public Assessment Report for Vaxzevria</a></h3>
    <p class="metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">1.08MB</span>, <span class="page-length" lang="en">65 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p>This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary data-track-category="Accessible Format Request" class="govuk-details__summary" data-track-action="FormatRequestClicked" data-track-label="Public Assessment Report for Vaxzevria" data-module="govuk-details" data-details-track-click="">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Public%20Assessment%20Report%20for%20Vaxzevria%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Public%20Assessment%20Report%20for%20Vaxzevria%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section>

</div>
  </section>


        <section>
          <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Details</h2>


          
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak direction-ltr">
    
            <div class="govspeak">
<p>On 24 June 2021, the MHRA issued a Conditional Marketing Authorisation (CMA) for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) in Great Britain (GB).  A CMA issued by the European Medicines Agency has had effect in Northern Ireland since 29 January 2021. To date, supply of the AstraZeneca vaccine in the UK has been authorised on a temporary basis by the MHRA under Regulation 174 of the Human Medicine Regulations 2012, but as this was always intended to be a temporary arrangement, supply of this vaccine will change to be in accordance with the CMAs.</p>

<p>Manufacture of the vaccine remains unchanged, as do the clinical, pharmacological and pharmaceutical properties of the vaccine.</p>

<p>The information for healthcare professionals and UK recipients on using the vaccine safely has been periodically updated as new data have become available and this will continue under the CMA. Please regularly check this information as it is often updated.</p>

<p>The COVID-19 Vaccine AstraZeneca authorised under Regulation 174 remains in use and its product information has been updated in line with the product information of the GB CMA.</p>

<p>The MHRA regularly publishes <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.gov.uk_government_publications_coronavirus-2Dcovid-2D19-2Dvaccine-2Dadverse-2Dreactions_coronavirus-2Dvaccine-2Dsummary-2Dof-2Dyellow-2Dcard-2Dreporting&amp;d=DwMFAw&amp;c=bXyEFqpHx20PVepeYtwgeyo6Hxa8iNFcGZACCQj1uNM&amp;r=RwY7gBVRFs7-J0I18jj3IoNV0FzvgEDZFBhtsTaYQtg&amp;m=EGsoy2Cpn4g8e77CUQnm1MpA2mn8TX0lqxp_PRUsdcs&amp;s=aIVqJ9ajG7JDJKKrAQY7D_vOycpVnt_X7zGVWwkrXf8&amp;e=" class="govuk-link" rel="external">reports of the safety of the COVID-19 vaccines</a>.</p>

<p>For further information on prioritising the first COVID-19 vaccine dose see the <a class="govuk-link" href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement">statement from the Joint Committee on Vaccination and Immunisation (JCVI).</a></p>

<h3>Summary of Product Characteristics (CMA)/Information for Healthcare Professionals (R174)</h3>
<p>This is a description of a medicinal productâ€™s properties and the conditions attached to its use. It explains how to use and prescribe a medicine. It is used by healthcare professionals, such as doctors, nurses and pharmacists.</p>

<h3>Patient Information Leaflet (CMA)/Information for UK Recipients (R174)</h3>
<p>The Patient Information Leaflet provides information for patients on using the medicine safely. This is based on the Summary of Product Characteristics of the product.</p>

<h3>Public Assessment Report</h3>
<p>The Public Assessment Report is a scientific report, written by the MHRA. It explains how this product was assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use this product.</p>

<h2>Ingredients</h2>

<p>The MHRA can confirm that Vaxzevria (previously COVID-19 Vaccine AstraZeneca) does not contain any components of animal origin.</p>

<p>A full list of ingredients for the qualitative and quantitative composition of the vaccine can be found at point 2 in the <a href="https://draft-origin.publishing.service.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca" class="govuk-link" rel="external">Summary of Product Characteristics</a> (CMA) and the <a class="govuk-link" href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174">Information for Healthcare Professionals</a> (R174).</p>

<p>A full list of ingredients for the excipient composition of the vaccine can be found at point 6.1 in the <a href="https://draft-origin.publishing.service.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca" rel="external" class="govuk-link">Summary of Product Characteristics</a> (CMA) and the <a href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174" class="govuk-link">Information for Healthcare Professionals</a> (R174).</p>

<p>A full list of ingredients for the qualitative and quantitative composition of the vaccine and a full list of the excipient composition of the vaccine can be found at point 6 in the <a rel="external" href="https://draft-origin.publishing.service.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca" class="govuk-link">Summary of Product Characteristics</a> (CMA) and the <a class="govuk-link" href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174">Information for Healthcare Professionals</a> (R174).</p>
</div>

</div>
        </section>
      </div>

      <div data-module="gem-toggle" lang="en" class="app-c-published-dates app-c-published-dates--history">
    Published 30 December 2020
    <br>Last updated 21 October 2021
      <a data-controls="full-history" data-toggled-text="-&nbsp;hide all updates" class="app-c-published-dates__toggle govuk-link" href="#full-history" data-expanded="false">+&nbsp;show all updates</a>
      <div class="app-c-published-dates__change-history js-hidden">
        <ol class="app-c-published-dates__list">
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-10-21T11:12:06.000+01:00" class="app-c-published-dates__change-date timestamp">21 October 2021</time>
              <p class="app-c-published-dates__change-note">Added Guillain-BarrÃ© syndrome [GBS] as a very rare side effect.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-10-19T10:00:12.000+01:00" class="app-c-published-dates__change-date timestamp">19 October 2021</time>
              <p class="app-c-published-dates__change-note">Updated information for healthcare professionals and for patients</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-09-09T07:01:18.000+01:00" class="app-c-published-dates__change-date timestamp">9 September 2021</time>
              <p class="app-c-published-dates__change-note">Updated sections of Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (Regulation 174) and Information for UK recipients on COVID-19 Vaccine AstraZeneca (Regulation 174) to include information about receiving a third dose. Also updated the Regulation 174 Conditions document with additional pharmacovigilance conditions.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-08-20T18:40:23.000+01:00" class="app-c-published-dates__change-date timestamp">20 August 2021</time>
              <p class="app-c-published-dates__change-note">Updated the PIL and Spc to include new warning on Guillaine-Barre Syndrome</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-07-19T15:16:28.000+01:00" class="app-c-published-dates__change-date timestamp">19 July 2021</time>
              <p class="app-c-published-dates__change-note">Added Lay summary, Vaxzevria (previously COVIDâ€‘19 Vaccine AstraZeneca, suspension for injection) COVID-19 Vaccine (ChAdOx1â€‘S [recombinant])</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-07-16T17:25:58.000+01:00" class="app-c-published-dates__change-date timestamp">16 July 2021</time>
              <p class="app-c-published-dates__change-note">Updated to reflect the addition of capillary leak syndrome as a contraindication. Also changed the name of the COVID-19 Vaccine AstraZeneca in the Conditional Marketing Authorisation product information to the brand name - Vaxzevria.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-06-25T07:02:50.000+01:00" class="app-c-published-dates__change-date timestamp">25 June 2021</time>
              <p class="app-c-published-dates__change-note">A Summary of Product Information, a Patient Information Leaflet and a Conditions of Authorisation for COVID-19 Vaccine AstraZeneca Conditional Marketing Authorisation have been added as the MHRA has issued a Conditional Marketing Authorisation for the vaccine. Updated versions of the Information for healthcare professionals and Information for UK recipients documents have also been added.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-04-15T15:24:12.000+01:00">15 April 2021</time>
              <p class="app-c-published-dates__change-note">Updated the Information for Healthcare Professionals and Information for UK Recipients on COVID-19 Vaccine AstraZeneca with new information about extremely rare, unlikely to occur blood clots.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-04-07T16:23:40.000+01:00" class="app-c-published-dates__change-date timestamp">7 April 2021</time>
              <p class="app-c-published-dates__change-note">Updated the Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca, with new information about extremely rare, unlikely to occur blood clots.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-02-23T14:45:28.000+00:00">23 February 2021</time>
              <p class="app-c-published-dates__change-note">All documents were updated to include updated side effect frequency and efficacy data, including a new table on efficacy by dosing interval in the Information for UK Healthcare Professionals document. A new Annex (Annex 1: Addition of manufacturer and importer) was added to the Conditions of Authorisation document.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-28T11:45:07.000+00:00">28 January 2021</time>
              <p class="app-c-published-dates__change-note">Published new versions of the Conditions of Authorisation documents, with an additional clause relating to off-label prescribing</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-07T15:13:32.000+00:00">7 January 2021</time>
              <p class="app-c-published-dates__change-note">Published a new version of the Information for UK healthcare professionals, adding new information in Section 6.6 allowing for an additional dose to be taken if there is sufficient for a further full dose to be taken from the vial.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-06T12:15:29.000+00:00">6 January 2021</time>
              <p class="app-c-published-dates__change-note">Added an accessible HTML version of the summary of the Public Assessment Report</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-01-05T16:13:38.000+00:00" class="app-c-published-dates__change-date timestamp">5 January 2021</time>
              <p class="app-c-published-dates__change-note">Publication of Public Assessment Report for AztraZeneca COVID-19 vaccine</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2020-12-30T10:47:00.000+00:00" class="app-c-published-dates__change-date timestamp">30 December 2020</time>
              <p class="app-c-published-dates__change-note">First published.</p>
            </li>
        </ol>
      </div>
</div>

    </div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav data-module="gem-toggle" role="navigation" class="gem-c-related-navigation__nav-section">

    <h2 data-track-count="footerRelatedItemSection" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="gem-track-click">


        <li class="gem-c-related-navigation__link"><a class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" href="/health-and-social-care/pharmacy" data-track-action="1.1 Explore the topic" data-track-category="relatedLinkClicked" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Pharmacy&quot;}" data-track-label="/health-and-social-care/pharmacy">Pharmacy</a></li>
        <li class="gem-c-related-navigation__link"><a data-track-action="1.2 Explore the topic" href="/coronavirus-taxon/vaccinations" data-track-label="/coronavirus-taxon/vaccinations" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Vaccinations for coronavirus&quot;}">Vaccinations for coronavirus</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>